We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Ways to link technology, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
A form of IP that extends the protection of patented active ingredients present in pharmaceutical or plant protection products.
Provides information on how the Pharmaceutical Price Regulation Scheme (PPRS) is controlling spend on branded medicines in the NHS.
The report presents a review of the evaluation of environmental risks posed by human pharmaceuticals.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
This study combines a review of data on pharmaceutical firms’ CSR with interviews of representatives from 6 firms
This guidance demonstrates stakeholders, including the government, working together to address supply issues.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
An independent tribunal responsible for handling appeals against decisions made by the Secretary of State for Health and Social Care from pharmaceutical companies.
Sets out the process for pharmaceutical companies to appeal against decisions made by the Secretary of State for Health and Social Care.
VICH consultation on the guideline relating to good manufacturing practice for active pharmaceutical ingredients used in veterinary medicinal products.
Guidance for industry on flexible approaches we are taking on good distribution practices.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
The Kenya Medical Supplies Authority (KEMSA) was the main case study identified for this report
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).